CORRECTING and REPLACING Nu Skin Enterprises Reports Third Quarter Earnings
Nu Skin Enterprises reported Q3 2026 revenue of $311.0M, down 14.6% y/y, with GAAP EPS of $(0.02) and adjusted EPS of $0.10. The company guided Q4 revenue to $310M-$340M and corrected prior tax and income figures. Revenue decline and GAAP loss were noted, but sequential growth is expected.
How this was made
The 30-second read
Why it matters
The corrected earnings release provides fresh data on revenue decline, GAAP loss, and tax rate, which are new to the market.
Market read
First‑report earnings with material miss; relevant for short‑term traders.
What to watch
Holiday‑season demand could exceed guidance, mitigating the revenue decline.
Background
Nu Skin Enterprises (NUS) is a U.S.-listed health‑care company focused on beauty and wellness products.
Ticker impact
Nu Skin reported Q3 2026 revenue down 14.6% YoY and GAAP EPS of -$0.02, issuing corrected nine‑month tax figures and guidance for Q4.
likely pressure as the market prices in the GAAP loss and elevated tax rate
Revenue decline and a GAAP loss are material; guidance is modest, so traders may short or reduce exposure.
Market effects
Health‑care/Other Pharmaceuticals may see broader scrutiny on tax‑rate impacts.
U.S. small‑cap consumer‑goods segment could face slight pullback.
Limited; primarily affects Nu Skin and its niche market.
Counterpoint
Adjusted EPS of $0.10 shows underlying profitability; could support a bounce if guidance improves.
Key entities
- CompanyNu Skin Enterprises
Issuer of the earnings release.
